Teva Chairman’s Other Drug Firm Buys Startup That Could Compete With Teva

Like Teva, startup Inspiro offers an inhaler for treating asthma and chronic obstructive pulmonary disease.

comments Print
In a move that raises a possible conflict of interest, biochemical drug company Opko Health announced over the weekend it is acquiring Israeli startup Inspiro. Opko is headed by the chairman of Teva...